IDEAYA Biosciences (IDYA) Accounts Payables (2018 - 2026)
IDEAYA Biosciences (IDYA) posted Accounts Payables of $20.7 million for Q1 2026, up 17.93% sequentially from $17.6 million in Q4 2025, and up 17.61% YoY from $17.6 million in Q1 2025.
IDEAYA Biosciences (IDYA) Accounts Payables (2018 - 2026) Analysis & Trends
IDEAYA Biosciences has reported Accounts Payables for 9 years, with the latest figure at $20.7 million in Q1 2026.
- Quarterly Accounts Payables rose 17.61% year-over-year to $20.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.7 million (up 17.61% YoY) and the FY2025 annual result came in at $17.6 million, up 14.03% from the prior year.
- Accounts Payables improved to $20.7 million in Q1 2026 per IDYA's latest filing, from $17.6 million in the prior quarter.
- Over five years, Accounts Payables peaked at $20.7 million in Q1 2026 and troughed at $3.4 million in Q1 2022.
- A 5-year average of $10.5 million and a median of $6.6 million in 2023 frame the typical range for Accounts Payables.
- The widest YoY moves for Accounts Payables: up 180.3% in 2025, down 8.71% in 2025.
- Over 5 years, Accounts Payables stood at $4.3 million in 2022, then surged by 54.16% to $6.6 million in 2023, then jumped by 133.72% to $15.4 million in 2024, then gained by 14.03% to $17.6 million in 2025, then increased by 17.93% to $20.7 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $20.7 million, $17.6 million, and $18.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | IDEAYA Biosciences | 3.50 Bn | 2.67 Bn | - | 30.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.51 Mn |
| Mar 31, 2026 | 20.74 Mn |
| Dec 31, 2025 | 17.58 Mn |
| Sep 30, 2025 | 18.43 Mn |
| Jun 30, 2025 | 17.27 Mn |
| Mar 31, 2025 | 17.63 Mn |
| Dec 31, 2024 | 15.42 Mn |
| Sep 30, 2024 | 12.57 Mn |
| Jun 30, 2024 | 15.89 Mn |
| Mar 31, 2024 | 6.29 Mn |
| Dec 31, 2023 | 6.60 Mn |
| Sep 30, 2023 | 5.17 Mn |
| Jun 30, 2023 | 5.87 Mn |
| Mar 31, 2023 | 4.38 Mn |
| Dec 31, 2022 | 4.28 Mn |
| Sep 30, 2022 | 3.65 Mn |
| Jun 30, 2022 | 4.23 Mn |
| Mar 31, 2022 | 3.36 Mn |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | 2.15 Mn |